Brookfield Asset Management Lowered Its Stake in American Tower New (AMT) by $33.86 Million; Cymabay (CBAY) Holder Abingworth Llp Has Cut Its Stake by $458,224 as Market Valuation Rose

February 24, 2018 - By Peter Erickson

Abingworth Llp decreased its stake in Cymabay (CBAY) by 3.58% based on its latest 2017Q3 regulatory filing with the SEC. Abingworth Llp sold 57,278 shares as the company’s stock rose 21.05% with the market. The institutional investor held 1.54 million shares of the major pharmaceuticals company at the end of 2017Q3, valued at $12.42M, down from 1.60M at the end of the previous reported quarter. Abingworth Llp who had been investing in Cymabay for a number of months, seems to be less bullish one the $814.51M market cap company. The stock increased 0.69% or $0.1 during the last trading session, reaching $14.69. About 611,729 shares traded. Cymabay Therapeutics, Inc. (NASDAQ:CBAY) has risen 69.26% since February 24, 2017 and is uptrending. It has outperformed by 52.56% the S&P500.

Brookfield Asset Management Inc decreased its stake in American Tower Corp New (AMT) by 9.47% based on its latest 2017Q3 regulatory filing with the SEC. Brookfield Asset Management Inc sold 249,000 shares as the company’s stock rose 18.69% with the market. The hedge fund held 2.38 million shares of the real estate investment trusts company at the end of 2017Q3, valued at $325.25M, down from 2.63M at the end of the previous reported quarter. Brookfield Asset Management Inc who had been investing in American Tower Corp New for a number of months, seems to be less bullish one the $60.84B market cap company. The stock increased 2.08% or $2.89 during the last trading session, reaching $141.87. About 1.93M shares traded. American Tower Corporation (NYSE:AMT) has risen 23.66% since February 24, 2017 and is uptrending. It has outperformed by 6.96% the S&P500.

Among 7 analysts covering Cymabay Therapeutics Inc (NASDAQ:CBAY), 7 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cymabay Therapeutics Inc had 21 analyst reports since July 21, 2015 according to SRatingsIntel. H.C. Wainwright maintained Cymabay Therapeutics, Inc. (NASDAQ:CBAY) rating on Wednesday, March 30. H.C. Wainwright has “Buy” rating and $6 target. Piper Jaffray maintained the shares of CBAY in report on Monday, September 11 with “Buy” rating. The rating was initiated by Cantor Fitzgerald on Tuesday, September 19 with “Buy”. As per Wednesday, June 1, the company rating was downgraded by H.C. Wainwright. H.C. Wainwright maintained Cymabay Therapeutics, Inc. (NASDAQ:CBAY) rating on Wednesday, January 4. H.C. Wainwright has “Neutral” rating and $2.50 target. H.C. Wainwright maintained it with “Buy” rating and $1200 target in Monday, July 17 report. The company was maintained on Wednesday, January 31 by Piper Jaffray. The stock of Cymabay Therapeutics, Inc. (NASDAQ:CBAY) earned “Buy” rating by H.C. Wainwright on Wednesday, January 24. The firm has “Buy” rating by Piper Jaffray given on Monday, July 17. The company was upgraded on Monday, January 30 by H.C. Wainwright.

Analysts await Cymabay Therapeutics, Inc. (NASDAQ:CBAY) to report earnings on March, 22. They expect $-0.17 EPS, up 43.33% or $0.13 from last year’s $-0.3 per share. After $-0.21 actual EPS reported by Cymabay Therapeutics, Inc. for the previous quarter, Wall Street now forecasts -19.05% EPS growth.

Brookfield Asset Management Inc, which manages about $13.20 billion and $21.37B US Long portfolio, upped its stake in Targa Res Corp (NYSE:TRGP) by 1.55M shares to 2.22M shares, valued at $105.02 million in 2017Q3, according to the filing. It also increased its holding in Ameren Corp (NYSE:AEE) by 13,700 shares in the quarter, for a total of 15,700 shares, and has risen its stake in Firstenergy Corp (NYSE:FE).

Among 19 analysts covering American Tower Corporation (NYSE:AMT), 18 have Buy rating, 0 Sell and 1 Hold. Therefore 95% are positive. American Tower Corporation had 68 analyst reports since August 6, 2015 according to SRatingsIntel. The company was maintained on Monday, August 28 by Citigroup. RBC Capital Markets maintained it with “Buy” rating and $153.0 target in Monday, October 2 report. As per Monday, September 11, the company rating was maintained by UBS. Jefferies maintained the stock with “Buy” rating in Monday, September 11 report. The stock of American Tower Corporation (NYSE:REIT) earned “Buy” rating by Citigroup on Thursday, June 16. The stock of American Tower Corporation (NYSE:REIT) has “Overweight” rating given on Thursday, August 24 by Morgan Stanley. Morgan Stanley maintained American Tower Corporation (NYSE:REIT) rating on Tuesday, November 14. Morgan Stanley has “Overweight” rating and $172 target. On Monday, August 24 the stock rating was downgraded by Zacks to “Buy”. RBC Capital Markets maintained the stock with “Buy” rating in Thursday, June 8 report. The company was maintained on Monday, November 2 by Stifel Nicolaus.

Investors sentiment increased to 1.2 in Q3 2017. Its up 0.04, from 1.16 in 2017Q2. It increased, as 36 investors sold AMT shares while 287 reduced holdings. 102 funds opened positions while 287 raised stakes. 378.31 million shares or 1.55% less from 384.25 million shares in 2017Q2 were reported. Tributary Limited Liability reported 5,500 shares. Hanson & Doremus holds 0% or 104 shares in its portfolio. Grand Jean Cap Mgmt reported 90,236 shares. Fort Washington Investment Advsr Inc Oh has 24,513 shares. Bessemer Group reported 5,553 shares. Apg Asset Management Nv reported 1.59 million shares. Alpha Windward Ltd holds 0.02% of its portfolio in American Tower Corporation (NYSE:REIT) for 235 shares. Jane Street Grp Inc Llc holds 87,568 shares. Kentucky Retirement reported 0.27% of its portfolio in American Tower Corporation (NYSE:REIT). Wellington Gru Limited Liability Partnership holds 0.7% of its portfolio in American Tower Corporation (NYSE:REIT) for 22.32 million shares. Middleton And Communications Ma, a Massachusetts-based fund reported 70,843 shares. Texas Yale Cap reported 0.12% stake. Bp Public Ltd Co has 0.43% invested in American Tower Corporation (NYSE:REIT). Crestwood Advsrs Group Ltd Limited Liability Company, Massachusetts-based fund reported 5,388 shares. Arrowstreet Cap Partnership owns 999,834 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts